Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI North America CPhI North America
Not Confirmed
Not Confirmed
20-22 May, 2025
Pharma Live ExpoPharma Live Expo
Not Confirmed
Not Confirmed
17-19 April, 2025
World Vaccine Conferen...World Vaccine Conference
Not Confirmed
Not Confirmed
22-24 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
Pharma Live ExpoPharma Live Expo
Industry Trade Show
Not Confirmed
17-19 April, 2025
World Vaccine Conferen...World Vaccine Conference
Industry Trade Show
Not Confirmed
22-24 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/how-trump-s-tariffs-on-imported-drugs-can-hurt-supply-chains-consumers-and-industry
04 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/04/3020240/0/en/Ardena-Completes-Acquisition-of-Advanced-Drug-Product-Manufacturing-Facility-from-Catalent-and-Expands-Bioanalytical-Services-in-North-America.html
18 Nov 2024
// PRESS RELEASE
https://ardena.com/news/ardenas-new-state-of-the-art-nanomedicine-facility-secures-full-gmp-approval-for-manufacturing/
29 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/29/2970687/0/en/Ardena-Expands-Bioanalytical-Services-in-Europe.html
15 Oct 2024
// REUTERS
https://www.reuters.com/markets/deals/catalent-sell-new-jersey-facility-2024-10-14/
14 Oct 2024
// PRESS RELEASE
https://ardena.com/news/ardena-signs-agreement-to-expand-us-footprint-with-the-acquisition-of-advanced-drug-product-manufacturing-facility-from-catalent/
16 Jul 2024
// PRESS RELEASE
https://ardena.com/news/ardena-announces-key-leadership-changes-to-drive-growth-and-international-expansion/
Details:
Under the agreement, Ardena will provide additional Good Manufacturing Practice (cGMP)-standard manufacturing capability for Race’s flagship intravenous (IV) formulation of RC220 (bisantrene dihydrochloride).
Lead Product(s): Bisantrene DiHCl
Therapeutic Area: Oncology Brand Name: RC220
Study Phase: PreclinicalProduct Type: Other Small Molecule
Sponsor: Race Oncology
Deal Size: $1.0 million Upfront Cash: Undisclosed
Deal Type: Agreement December 07, 2023
Lead Product(s) : Bisantrene DiHCl
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : Race Oncology
Deal Size : $1.0 million
Deal Type : Agreement
Ardena Signs Agreement with Race Oncology Limited to Manufacture RC220
Details : Under the agreement, Ardena will provide additional Good Manufacturing Practice (cGMP)-standard manufacturing capability for Race’s flagship intravenous (IV) formulation of RC220 (bisantrene dihydrochloride).
Product Name : RC220
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
December 07, 2023
Services
Packaging
Analytical
API Manufacturing
Drug Product Manufacturing
API & Drug Product Development
ABOUT THIS PAGE
Ardena is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Atazanavir Sulfate bulk offered by Ardena